Daniel G. Anderson
Research associate, David H. Koch Institute for Integrative Cancer Research
areas of expertise: cancer, drug delivery, genetic therapy, sirna delivery, biomaterials
Daniel G. Anderson is appointed at the David H. Koch Institute for Integrative Cancer Research at MIT.
At MIT, he pioneered the use of robotic methods for the development of smart biomaterials for drug delivery and tissue engineering. He has developed methods allowing rapid synthesis, formulation, analysis and biological testing of large libraries of biomaterials for use in medical devices, cell therapy and drug delivery. In particular, the advanced drug delivery systems he has developed provide new methods for nanoparticulate and microparticulate drug delivery, nonviral gene therapy, siRNA delivery and vaccines.
His work has resulted in the publication of more than 110 papers, patents and patent applications. These patents have led to a number of licenses to pharmaceutical, chemical and biotechnology companies.
He received his PhD in molecular genetics from the University of California at Davis.
request an interview: Sarah McDonnell | 617-253-8923 | s_mcd@mit.edu